Wealthspring Capital’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,006,939
Closed -$10.9M 213
2026
Q1
$10.9M Sell
1,006,939
-11,343
-1% -$122K 2.59% 5
2025
Q4
$10.9M Sell
1,018,282
-13,581
-1% -$145K 2.57% 5
2025
Q3
$10.9M Sell
1,031,863
-27,179
-3% -$287K 2.6% 6
2025
Q2
$11.2M Buy
1,059,042
+849,783
+406% +$8.89M 2.95% 6
2025
Q1
$2.15M Sell
209,259
-12,575
-6% -$129K 3.32% 11
2024
Q4
$2.25M Sell
221,834
-32,119
-13% -$324K 3.4% 9
2024
Q3
$2.56M Buy
+253,953
New +$2.55M 3.16% 13

Other funds holding GPAT

Wealthspring Capital's GPAT Position: Q2 2026 in Review

Wealthspring Capital sold out of GP-Act III Acquisition Corp (GPAT) in Q2 2026, closing a stake of 1,006,939 shares — an estimated $10.9M sold.

Wealthspring Capital first reported a position in GPAT in Q3 2024 and held it in 7 quarters. The position peaked at $11.2M in Q2 2025. 4 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • Wealthspring Capital reported no remaining GP-Act III Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Wealthspring Capital sold 1,006,939 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $10.9M.
  • Wealthspring Capital first reported a position in GP-Act III Acquisition Corp in Q3 2024 and held it in 7 quarters.
  • Wealthspring Capital's GP-Act III Acquisition Corp position peaked at $11.2M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on Wealthspring Capital's 13F filing for Q2 2026, filed 15 Jul 2026.